Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027

Global and Japan Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027

Table of Contents
1 STUDY COVERAGE 1
1.1 Beta-lactam and Beta-lactamase Inhibitors Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type 2
1.2.2 Penicillins 3
1.2.3 Cephalosporins 6
1.2.4 Carbapenems 9
1.2.5 Monobactams 11
1.3 Market by Application 12
1.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Application 12
1.3.2 Oral 13
1.3.3 Intravenous 14
1.4 Study Objectives 14
1.5 Years Considered 15
2 EXECUTIVE SUMMARY 16
2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Estimates and Forecasts 16
2.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Revenue 2016-2027 16
2.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales 2016-2027 17
2.2 Beta-lactam and Beta-lactamase Inhibitors Market Size by Region: 2016 VS 2021 VS 2027 18
2.3 Beta-lactam and Beta-lactamase Inhibitors Historical Market Size by Region (2016-2027) 18
2.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021 18
2.3.2 Global Beta-lactam and Beta-lactamase Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021 19
2.4 Beta-lactam and Beta-lactamase Inhibitors Market Estimates and Projections by Region (2022-2027) 20
2.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Region (2022-2027) 20
2.4.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Region (2022-2027) 21
3 GLOBAL BETA-LACTAM AND BETA-LACTAMASE INHIBITORS COMPETITOR LANDSCAPE BY PLAYERS 23
3.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Manufacturers by Sales 23
3.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales by Manufacturer (2016-2021) 23
3.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Manufacturer (2016-2021) 24
3.2 Global Top Beta-lactam and Beta-lactamase Inhibitors Manufacturers by Revenue 25
3.2.1 Key Beta-lactam and Beta-lactamase Inhibitors Manufacturers Covered: Ranking by Revenue 25
3.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Manufacturer (2016-2021) 26
3.2.3 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Manufacturer (2016-2021) 27
3.2.4 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio (CR5 and HHI) & (2016-2021) 28
3.2.5 Global Top 10 and Top 5 Companies by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020 29
3.2.6 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 30
3.3 Global Beta-lactam and Beta-lactamase Inhibitors Price by Manufacturer (2016-2021) 31
3.4 Global Beta-lactam and Beta-lactamase Inhibitors Manufacturing Base Distribution, Product Type 32
3.4.1 Beta-lactam and Beta-lactamase Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters 32
3.4.2 Manufacturers Beta-lactam and Beta-lactamase Inhibitors Product Type 32
3.4.3 Date of International Manufacturers Enter into Beta-lactam and Beta-lactamase Inhibitors Market 33
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 34
4 BREAKDOWN DATA BY TYPE (2016-2027) 36
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) 36
4.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021) 36
4.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type (2016-2021) 37
4.1.3 Beta-lactam and Beta-lactamase Inhibitors Average Selling Price (ASP) by Type (2016-2021) 38
4.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast by Type (2022-2027) 39
4.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Type (2022-2027) 39
4.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Type (2022-2027) 39
4.2.3 Global Beta-lactam and Beta-lactamase Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027) 40
5 BREAKDOWN DATA BY APPLICATION (2016-2027) 41
5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) 41
5.1.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021) 41
5.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application (2016-2021) 42
5.1.3 Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2021) 43
5.2 Beta-lactam and Beta-lactamase Inhibitors Market Size Forecast by Application (2022-2027) 43
5.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Application (2022-2027) 43
5.2.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Application (2022-2027) 44
5.2.3 Global Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Application (2022-2027) 44
6 JAPAN BY PLAYERS, BY TYPE AND BY APPLICATION 46
6.1 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027 46
6.1.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales YoY Growth 2016-2027 46
6.1.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue YoY Growth 2016-2027 47
6.1.3 Japan Beta-lactam and Beta-lactamase Inhibitors Market Share in Global Market 2016-2027 48
6.2 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Players (International and Local Players) 48
6.2.1 Japan Top Beta-lactam and Beta-lactamase Inhibitors Players by Sales (2016-2021) 49
6.2.2 Japan Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue (2016-2021) 50
6.3 Japan Beta-lactam and Beta-lactamase Inhibitors Historic Market Review by Type (2016-2021) 53
6.3.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type (2016-2021) 53
6.3.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2021) 53
6.3.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price by Type (2016-2021) 54
6.4 Japan Beta-lactam and Beta-lactamase Inhibitors Market Estimates and Forecasts by Type (2022-2027) 54
6.4.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Type (2022-2027) 54
6.4.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Type (2022-2027) 55
6.4.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Type (2022-2027) 56
6.5 Japan Beta-lactam and Beta-lactamase Inhibitors Historic Market Review by Application (2016-2021) 56
6.5.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application (2016-2021) 56
6.5.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2016-2021) 57
6.5.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2021) 57
6.6 Japan Beta-lactam and Beta-lactamase Inhibitors Market Estimates and Forecasts by Application (2022-2027) 58
6.6.1 Japan Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Application (2022-2027) 58
6.6.2 Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Application (2022-2027) 58
6.6.3 Japan Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Application (2022-2027) 59
7 NORTH AMERICA 60
7.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027 60
7.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country 61
7.2.1 North America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) 61
7.2.2 North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) 62
7.2.3 U.S. 63
7.2.4 Canada 64
8 ASIA-PACIFIC 65
8.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027 65
8.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Region 66
8.2.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2016-2021) 66
8.2.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2021) 67
8.2.3 China 68
8.2.4 Japan 69
8.2.5 South Korea 70
8.2.6 India 71
8.2.7 Australia 72
8.2.8 Indonesia 73
8.2.9 Thailand 74
8.2.10 Malaysia 75
8.2.11 Philippines 76
9 EUROPE 78
9.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027 78
9.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country 79
9.2.1 Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) 79
9.2.2 Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) 80
9.2.3 Germany 81
9.2.4 France 82
9.2.5 U.K. 83
9.2.6 Italy 84
9.2.7 Russia 85
10 LATIN AMERICA 86
10.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027 86
10.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country 87
10.2.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) 87
10.2.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) 88
10.2.3 Mexico 89
10.2.4 Brazil 90
10.2.5 Argentina 91
11 MIDDLE EAST AND AFRICA 92
11.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2016-2027 92
11.2 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Market Facts & Figures by Country 93
11.2.1 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) 93
11.2.2 Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) 94
11.2.3 Turkey 95
11.2.4 Saudi Arabia 96
11.2.5 UAE 97
12 COMPANY PROFILES 98
12.1 Pfizer 98
12.1.1 Pfizer Corporation Information 98
12.1.2 Pfizer Description and Business Overview 98
12.1.3 Pfizer Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 99
12.1.4 Pfizer Beta-lactam and Beta-lactamase Inhibitors Products Offered 99
12.2 Novartis (Sandoz) 102
12.2.1 Novartis (Sandoz) Corporation Information 102
12.2.2 Novartis (Sandoz) Description and Business Overview 102
12.2.3 Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 103
12.2.4 Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Products Offered 103
12.3 TEVA 106
12.3.1 TEVA Corporation Information 106
12.3.2 TEVA Description and Business Overview 107
12.3.3 TEVA Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 107
12.3.4 TEVA Beta-lactam and Beta-lactamase Inhibitors Products Offered 107
12.4 Merck 109
12.4.1 Merck Corporation Information 109
12.4.2 Merck Description and Business Overview 109
12.4.3 Merck Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 110
12.4.4 Merck Beta-lactam and Beta-lactamase Inhibitors Products Offered 110
12.5 AbbVie (Allergan) 110
12.5.1 AbbVie (Allergan) Corporation Information 110
12.5.2 AbbVie (Allergan) Description and Business Overview 111
12.5.3 AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 111
12.5.4 AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Products Offered 111
12.6 Sumitomo Dainippon 112
12.6.1 Sumitomo Dainippon Corporation Information 112
12.6.2 Sumitomo Dainippon Description and Business Overview 112
12.6.3 Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 113
12.6.4 Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Products Offered 113
12.7 Hikma 113
12.7.1 Hikma Corporation Information 113
12.7.2 Hikma Description and Business Overview 114
12.7.3 Hikma Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 114
12.7.4 Hikma Beta-lactam and Beta-lactamase Inhibitors Products Offered 114
12.8 Aurobindo Pharma 116
12.8.1 Aurobindo Pharma Corporation Information 116
12.8.2 Aurobindo Pharma Description and Business Overview 116
12.8.3 Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 116
12.8.4 Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Products Offered 117
12.9 Wockhardt 117
12.9.1 Wockhardt Corporation Information 117
12.9.2 Wockhardt Description and Business Overview 118
12.9.3 Wockhardt Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 118
12.9.4 Wockhardt Beta-lactam and Beta-lactamase Inhibitors Products Offered 118
12.10 Lupin Limited 118
12.10.1 Lupin Limited Corporation Information 118
12.10.2 Lupin Limited Description and Business Overview 119
12.10.3 Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 119
12.10.4 Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Products Offered 119
12.11 Fresenius Kabi 122
12.11.1 Fresenius Kabi Corporation Information 122
12.11.2 Fresenius Kabi Description and Business Overview 122
12.11.3 Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 123
12.11.4 Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Products Offered 123
12.12 B. Braun 124
12.12.1 B. Braun Corporation Information 124
12.12.2 B. Braun Description and Business Overview 124
12.12.3 B. Braun Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 124
12.12.4 B. Braun Beta-lactam and Beta-lactamase Inhibitors Products Offered 125
12.13 USantibiotics 125
12.13.1 USantibiotics Corporation Information 125
12.13.2 USantibiotics Description and Business Overview 126
12.13.3 USantibiotics Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 126
12.13.4 USantibiotics Beta-lactam and Beta-lactamase Inhibitors Products Offered 126
12.14 Qilu Pharmaceutical 127
12.14.1 Qilu Pharmaceutical Corporation Information 127
12.14.2 Qilu Pharmaceutical Description and Business Overview 127
12.14.3 Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 128
12.14.4 Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Products Offered 128
12.15 ACS Dobfar 128
12.15.1 ACS Dobfar Corporation Information 128
12.15.2 ACS Dobfar Description and Business Overview 129
12.15.3 ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 129
12.15.4 ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Products Offered 129
12.16 Nichi-Iko (Sagent) 131
12.16.1 Nichi-Iko (Sagent) Corporation Information 131
12.16.2 Nichi-Iko (Sagent) Description and Business Overview 131
12.16.3 Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 132
12.16.4 Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Products Offered 132
12.17 Antibiotice 135
12.17.1 Antibiotice Corporation Information 135
12.17.2 Antibiotice Description and Business Overview 135
12.17.3 Antibiotice Beta-lactam and Beta-lactamase Inhibitors Sales, Revenue and Gross Margin (2016-2021) 136
12.17.4 Antibiotice Beta-lactam and Beta-lactamase Inhibitors Products Offered 136
13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES FACTORS ANALYSIS 138
13.1 Beta-lactam and Beta-lactamase Inhibitors Industry Trends 138
13.2 Beta-lactam and Beta-lactamase Inhibitors Market Drivers 138
13.3 Beta-lactam and Beta-lactamase Inhibitors Market Challenges 139
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS 140
14.1 Value Chain Analysis 140
14.2 Beta-lactam and Beta-lactamase Inhibitors Customers 140
14.3 Sales Channels Analysis 141
14.3.1 Sales Channels 141
14.3.2 Distributors 142
15 RESEARCH FINDINGS AND CONCLUSION 145
16 APPENDIX 146
16.1 Research Methodology 146
16.1.1 Methodology/Research Approach 146
16.1.2 Data Source 149
16.2 Author Details 152
16.3 Disclaimer 152
?
List of Tables and Figures
Table 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) 2
Table 2. Penicillins of Current and Historical Uses 4
Table 3. Cephalosporins of Current Clinical Utility or of Historical Interest 7
Table 4. Major Manufacturers of Cephalosporins 8
Table 5. Carbapenems of Current Clinical Utility 9
Table 6. Major Manufacturers of Carbapenems 10
Table 7. Carbapenems of Current Clinical Utility 11
Table 8. Major Manufacturers of Monobactams 12
Table 9. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) 12
Table 10. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (US$ Million): 2016 VS 2021 VS 2027 18
Table 11. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2016-2021) & (M Unit) 18
Table 12. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Region (2016-2021) 18
Table 13. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2021) & (US$ Million) 19
Table 14. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Region (2016-2021) 20
Table 15. Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Region (2022-2027) & (M Unit) 20
Table 16. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share Forecast by Region (2022-2027) 21
Table 17. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million) 21
Table 18. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share Forecast by Region (2022-2027) 21
Table 19. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Manufacturer (2016-2021) & (M Unit) 23
Table 20. Global Beta-lactam and Beta-lactamase Inhibitors Sales Share by Manufacturer (2016-2021) 24
Table 21. Ranking of Global Top Beta-lactam and Beta-lactamase Inhibitors Manufacturers by Revenue (US$ Million) in 2020 26
Table 22. Beta-lactam and Beta-lactamase Inhibitors Revenue by Manufacturer (2016-2021) & (US$ Million) 26
Table 23. Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Manufacturer (2016-2021) 27
Table 24. Global Beta-lactam and Beta-lactamase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) 28
Table 25. Global Beta-lactam and Beta-lactamase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2020) 30
Table 26. Key Manufacturers Beta-lactam and Beta-lactamase Inhibitors Price (2016-2021) & (US$/Unit) 31
Table 27. Beta-lactam and Beta-lactamase Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters 32
Table 28. Manufacturers Beta-lactam and Beta-lactamase Inhibitors Product Type 33
Table 29. Date of International Manufacturers Establishing 33
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans 34
Table 31. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Type (2016-2021) & (M Unit) 36
Table 32. Global Beta-lactam and Beta-lactamase Inhibitors Sales Share by Type (2016-2021) 36
Table 33. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Type (2016-2021) & (US$ Million) 37
Table 34. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Type (2016-2021) 37
Table 35. Beta-lactam and Beta-lactamase Inhibitors Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) 38
Table 36. Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Type (2022-2027) & (M Unit) 39
Table 37. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share Forecast by Type (2022-2027) 39
Table 38. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million) 39
Table 39. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share Forecast by Type (2022-2027) 40
Table 40. Global Beta-lactam and Beta-lactamase Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) 40
Table 41. Global Beta-lactam and Beta-lactamase Inhibitors Sales by Application (2016-2021) & (M Unit) 41
Table 42. Global Beta-lactam and Beta-lactamase Inhibitors Sales Share by Application (2016-2021) 41
Table 43. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Application (2016-2021) & (US$ Million) 42
Table 44. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Application (2016-2021) 42
Table 45. Beta-lactam and Beta-lactamase Inhibitors Price by Application (2016-2021) & (US$/Unit) 43
Table 46. Global Beta-lactam and Beta-lactamase Inhibitors Sales Forecast by Application (2022-2027) & (M Unit) 43
Table 47. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share Forecast by Application (2022-2027) 44
Table 48. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million) 44
Table 49. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share Forecast by Application (2022-2027) 44
Table 50. Global Beta-lactam and Beta-lactamase Inhibitors Price Forecast by Application (2022-2027) & (US$/Unit) 44
Table 51. Japan Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit) of Key Companies (2016-2021) 49
Table 52. Japan Beta-lactam and Beta-lactamase Inhibitors Sales Share by Company (2016-2021) 49
Table 53. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue (US$ Million) by Company (2016-2021) 50
Table 54. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Company (2016-2021) 51
Table 55. Japan Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit) by Type (2016-2021) 53
Table 56. Japan Beta-lactam and Beta-lactamase Inhibitors Sales Share by Type (2016-2021) 53
Table 57. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021) 53
Table 58. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Type (2016-2021) 54
Table 59. Japan Beta-lactam and Beta-lactamase Inhibitors Price (US$/Unit) by Type (2016-2021) 54
Table 60. Japan Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit) by Type (2022-2027) 54
Table 61. Japan Beta-lactam and Beta-lactamase Inhibitors Sales Share by Type (2022-2027) 55
Table 62. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027) 55
Table 63. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Type (2022-2027) 55
Table 64. Japan Beta-lactam and Beta-lactamase Inhibitors Price (US$/Unit) by Type (2022-2027) 56
Table 65. Japan Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit) by Application (2016-2021) 56
Table 66. Japan Beta-lactam and Beta-lactamase Inhibitors Sales Share by Application (2016-2021) 56
Table 67. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021) 57
Table 68. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Application (2016-2021) 57
Table 69. Japan Beta-lactam and Beta-lactamase Inhibitors Price (US$/Unit) by Application (2016-2021) 57
Table 70. Japan Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit) by Application (2022-2027) 58
Table 71. Japan Beta-lactam and Beta-lactamase Inhibitors Sales Share by Application (2022-2027) 58
Table 72. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027) 58
Table 73. Japan Beta-lactam and Beta-lactamase Inhibitors Revenue Share by Application (2022-2027) 59
Table 74. Japan Beta-lactam and Beta-lactamase Inhibitors Price (US$/Unit) by Application (2022-2027) 59
Table 75. North America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) & (M Unit) 61
Table 76. North America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2021) 61
Table 77. North America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) & (US$ Million) 62
Table 78. North America Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2021) 62
Table 79. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales by Region (2016-2021) & (M Unit) 66
Table 80. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Region (2016-2021) 67
Table 81. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue by Region (2016-2021) & (US$ Million) 67
Table 82. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Region (2016-2021) 68
Table 83. Europe Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) & (M Unit) 79
Table 84. Europe Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2021) 80
Table 85. Europe Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) & (US$ Million) 80
Table 86. Europe Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2021) 80
Table 87. Latin America Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) & (M Unit) 87
Table 88. Latin America Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2021) 88
Table 89. Latin America Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) & (US$ Million) 88
Table 90. Latin America Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2021) 88
Table 91. Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Sales by Country (2016-2021) & (M Unit) 93
Table 92. Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Country (2016-2021) 94
Table 93. Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue by Country (2016-2021) & (US$ Million) 94
Table 94. Middle East and Africa Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Country (2016-2021) 94
Table 95. Pfizer Corporation Information 98
Table 96. Pfizer Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 99
Table 97. Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Product 99
Table 98. Novartis (Sandoz) Corporation Information 102
Table 99. Novartis (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 103
Table 100. Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product 103
Table 101. TEVA Corporation Information 106
Table 102. TEVA Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 107
Table 103. Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Product 107
Table 104. Merck Corporation Information 109
Table 105. Merck Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 110
Table 106. Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Product 110
Table 107. AbbVie (Allergan) Corporation Information 110
Table 108. AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 111
Table 109. AbbVie (Allergan) Beta-lactam and Beta-lactamase Inhibitors Product 111
Table 110. Sumitomo Dainippon Corporation Information 112
Table 111. Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 113
Table 112. Sumitomo Dainippon Beta-lactam and Beta-lactamase Inhibitors Product 113
Table 113. Hikma Corporation Information 113
Table 114. Hikma Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 114
Table 115. Hikma Beta-lactam and Beta-lactamase Inhibitors Product 114
Table 116. Aurobindo Pharma Corporation Information 116
Table 117. Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 116
Table 118. Aurobindo Pharma Beta-lactam and Beta-lactamase Inhibitors Product 117
Table 119. Wockhardt Corporation Information 117
Table 120. Wockhardt Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 118
Table 121. Wockhardt Beta-lactam and Beta-lactamase Inhibitors Product 118
Table 122. Lupin Limited Corporation Information 118
Table 123. Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 119
Table 124. Lupin Limited Beta-lactam and Beta-lactamase Inhibitors Product 119
Table 125. Fresenius Kabi Corporation Information 122
Table 126. Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 123
Table 127. Fresenius Kabi Beta-lactam and Beta-lactamase Inhibitors Product 123
Table 128. B. Braun Corporation Information 124
Table 129. B. Braun Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 124
Table 130. B. Braun Beta-lactam and Beta-lactamase Inhibitors Product 125
Table 131. USantibiotics Corporation Information 125
Table 132. USantibiotics Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 126
Table 133. Qilu Pharmaceutical Corporation Information 127
Table 134. Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 128
Table 135. Qilu Pharmaceutical Beta-lactam and Beta-lactamase Inhibitors Product 128
Table 136. ACS Dobfar Corporation Information 128
Table 137. ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 129
Table 138. ACS Dobfar Beta-lactam and Beta-lactamase Inhibitors Product 129
Table 139. Nichi-Iko (Sagent) Corporation Information 131
Table 140. Nichi-Iko (Sagent) Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 132
Table 141. Nichi-Iko (Sagent Pharma) Beta-lactam and Beta-lactamase Inhibitors Product 132
Table 142. Antibiotice Corporation Information 135
Table 143. Antibiotice Beta-lactam and Beta-lactamase Inhibitors Sales (M Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) 136
Table 144. Antibiotice Beta-lactam and Beta-lactamase Inhibitors Product 136
Table 145. Beta-lactam and Beta-lactamase Inhibitors Customers List 140
Table 146. Beta-lactam and Beta-lactamase Inhibitors Distributors List 142
Table 147. Research Programs/Design for This Report 146
Table 148. Key Data Information from Secondary Sources 149
Table 149. Key Data Information from Primary Sources 151
?
List of Figures
Figure 1. Timeline of ?-Lactam Antibiotics 1
Figure 2. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Type in 2020 & 2027 3
Figure 3. Penicillins Product Picture 4
Figure 4. Major Manufacturers of Penicillins 6
Figure 5. Cephalosporins Product Picture 6
Figure 6. Carbapenems Product Picture 9
Figure 7. Monobactams Product Picture 11
Figure 8. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application in 2020 & 2027 13
Figure 9. Oral 14
Figure 10. Intravenous 14
Figure 11. Beta-lactam and Beta-lactamase Inhibitors Report Years Considered 15
Figure 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Size, (US$ Million), 2016 VS 2021 VS 2027 16
Figure 13. Global Beta-lactam and Beta-lactamase Inhibitors Market Size 2016-2027 (US$ Million) 17
Figure 14. Global Beta-lactam and Beta-lactamase Inhibitors Sales 2016-2027 (M Unit) 17
Figure 15. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Region in 2020 19
Figure 16. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Region in 2020 20
Figure 17. Global Beta-lactam and Beta-lactamase Inhibitors Sales Share by Manufacturer in 2020 25
Figure 18. The Top 10 and 5 Players Market Share by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020 29
Figure 19. Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 31
Figure 20. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Type in 2020 37
Figure 21. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type in 2020 38
Figure 22. Global Beta-lactam and Beta-lactamase Inhibitors Sales Market Share by Application in 2020 42
Figure 23.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs